View in EDS HTML Full Text PDF Full Text

Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study.

Saved in:
Bibliographic Details
Title: Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study.
Authors: Clark ED; Alzheimer's Disease Care, Research and Education Program (AD-CARE), Department of Psychiatry University of Rochester School of Medicine and Dentistry Rochester New York USA., Perin J; Department of International Health Johns Hopkins University Bloomberg School of Public Health Baltimore Maryland USA., Herrmann N; Sunnybrook Research Institute University of Toronto Toronto Ontario Canada., Brawman-Mintzer O; Ralph H. Johnson VA Medical Center, Department of Psychiatry Medical University of South Carolina Charleston South Carolina USA., Lanctôt KL; Hurvitz Brain Science Research Program, Sunnybrook Research Institute, Departments of Psychiatry and Pharmacology University of Toronto Toronto Ontario Canada., Lerner AJ; Department of Neurology University Hospitals Cleveland Medical Center Case Western Reserve University School of Medicine Cleveland Ohio USA., Mintzer J; Ralph H. Johnson VA Medical Center, Department of Psychiatry Medical University of South Carolina Charleston South Carolina USA., Padala PR; Central Arkansas Veterans Healthcare System Baptist Health-University of Arkansas for Medical Sciences Little Rock Arkansas USA., Rosenberg PB; Departments of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA., Sami S; Department of Neurology University Hospitals Cleveland Medical Center Case Western Reserve University School of Medicine Cleveland Ohio USA., Shade DM; Department of Epidemiology Johns Hopkins University Bloomberg School of Public Health Baltimore Maryland USA., van Dyck CH; Departments of Psychiatry, Neurology, and Neuroscience Yale School of Medicine New Haven Connecticut USA., Porsteinsson AP; Alzheimer's Disease Care, Research and Education Program (AD-CARE), Department of Psychiatry University of Rochester School of Medicine and Dentistry Rochester New York USA.
Corporate Authors: ADMET‐2 Study Group
Source: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2023 Aug 02; Vol. 9 (3), pp. e12403. Date of Electronic Publication: 2023 Aug 02 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37538343
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Clark+ED%22">Clark ED</searchLink>; Alzheimer's Disease Care, Research and Education Program (AD-CARE), Department of Psychiatry University of Rochester School of Medicine and Dentistry Rochester New York USA.<br /><searchLink fieldCode="AU" term="%22Perin+J%22">Perin J</searchLink>; Department of International Health Johns Hopkins University Bloomberg School of Public Health Baltimore Maryland USA.<br /><searchLink fieldCode="AU" term="%22Herrmann+N%22">Herrmann N</searchLink>; Sunnybrook Research Institute University of Toronto Toronto Ontario Canada.<br /><searchLink fieldCode="AU" term="%22Brawman-Mintzer+O%22">Brawman-Mintzer O</searchLink>; Ralph H. Johnson VA Medical Center, Department of Psychiatry Medical University of South Carolina Charleston South Carolina USA.<br /><searchLink fieldCode="AU" term="%22Lanctôt+KL%22">Lanctôt KL</searchLink>; Hurvitz Brain Science Research Program, Sunnybrook Research Institute, Departments of Psychiatry and Pharmacology University of Toronto Toronto Ontario Canada.<br /><searchLink fieldCode="AU" term="%22Lerner+AJ%22">Lerner AJ</searchLink>; Department of Neurology University Hospitals Cleveland Medical Center Case Western Reserve University School of Medicine Cleveland Ohio USA.<br /><searchLink fieldCode="AU" term="%22Mintzer+J%22">Mintzer J</searchLink>; Ralph H. Johnson VA Medical Center, Department of Psychiatry Medical University of South Carolina Charleston South Carolina USA.<br /><searchLink fieldCode="AU" term="%22Padala+PR%22">Padala PR</searchLink>; Central Arkansas Veterans Healthcare System Baptist Health-University of Arkansas for Medical Sciences Little Rock Arkansas USA.<br /><searchLink fieldCode="AU" term="%22Rosenberg+PB%22">Rosenberg PB</searchLink>; Departments of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA.<br /><searchLink fieldCode="AU" term="%22Sami+S%22">Sami S</searchLink>; Department of Neurology University Hospitals Cleveland Medical Center Case Western Reserve University School of Medicine Cleveland Ohio USA.<br /><searchLink fieldCode="AU" term="%22Shade+DM%22">Shade DM</searchLink>; Department of Epidemiology Johns Hopkins University Bloomberg School of Public Health Baltimore Maryland USA.<br /><searchLink fieldCode="AU" term="%22van+Dyck+CH%22">van Dyck CH</searchLink>; Departments of Psychiatry, Neurology, and Neuroscience Yale School of Medicine New Haven Connecticut USA.<br /><searchLink fieldCode="AU" term="%22Porsteinsson+AP%22">Porsteinsson AP</searchLink>; Alzheimer's Disease Care, Research and Education Program (AD-CARE), Department of Psychiatry University of Rochester School of Medicine and Dentistry Rochester New York USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ADMET‐2+Study+Group%22">ADMET‐2 Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101650118%22">Alzheimer's & dementia (New York, N. Y.)</searchLink> [Alzheimers Dement (N Y)] 2023 Aug 02; Vol. 9 (3), pp. e12403. <i>Date of Electronic Publication: </i>2023 Aug 02 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+on+behalf+of+the+Alzheimer's+Association%22">Wiley on behalf of the Alzheimer's Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101650118 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-8737 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223528737%22">23528737 </searchLink><i>NLM ISO Abbreviation: </i>Alzheimers Dement (N Y) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37538343
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/trc2.12403
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e12403
    Titles:
      – TitleFull: Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Clark ED
      – PersonEntity:
          Name:
            NameFull: Perin J
      – PersonEntity:
          Name:
            NameFull: Herrmann N
      – PersonEntity:
          Name:
            NameFull: Brawman-Mintzer O
      – PersonEntity:
          Name:
            NameFull: Lanctôt KL
      – PersonEntity:
          Name:
            NameFull: Lerner AJ
      – PersonEntity:
          Name:
            NameFull: Mintzer J
      – PersonEntity:
          Name:
            NameFull: Padala PR
      – PersonEntity:
          Name:
            NameFull: Rosenberg PB
      – PersonEntity:
          Name:
            NameFull: Sami S
      – PersonEntity:
          Name:
            NameFull: Shade DM
      – PersonEntity:
          Name:
            NameFull: van Dyck CH
      – PersonEntity:
          Name:
            NameFull: Porsteinsson AP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 08
              Text: 2023 Aug 02
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2352-8737
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Alzheimer's & dementia (New York, N. Y.)
              Type: main
ResultId 1